Literature DB >> 7588840

Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii.

B Mulin1, D Talon, J F Viel, C Vincent, R Leprat, M Thouverez, Y Michel-Briand.   

Abstract

A six-month prospective survey was carried out in a university hospital to assess the incidence of Acinetobacter baumannii cross-contamination and to identify risk factors for colonization. Clinical isolates obtained during the study period were biotyped and genotyped by pulsed-field gel electrophoresis after ApaI macrorestriction of total DNA. Case-control univariate and multivariate analyses were performed to identify risk factors for Acinetobacter baumannii colonization. One hundred forty-seven patients hospitalized in 36 units were colonized or infected, of whom 52 were in three intensive care units. The urinary (29%) and bronchopulmonary tracts (26%) were the most frequently colonized sites. Nine major restriction patterns were identified: two were exhibited by epidemic multi-resistant strains of biotype 9 which were isolated from 65 patients hospitalized in ten units. Multivariate analysis showed that case-patients were (a) more likely than non-infected controls to be male, to have been previously hospitalized in another unit and to have had longer stays in the unit before colonization and hyperalimentation; and (b) more likely than controls colonized with other gram-negative bacilli to be male, to have had longer hospitalization, to have received treatment with third-generation cephalosporins and to have had a urinary catheter. The high incidence of colonization with Acinetobacter baumannii can thus be attributed to frequent cross-contamination and the use of broad-spectrum antibiotics. Colonized patients appear to be the major source of cross-contamination as epidemic strains spread throughout the hospital.

Entities:  

Mesh:

Year:  1995        PMID: 7588840     DOI: 10.1007/BF01690727

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  THE HUMAN SKIN AS A SOURCE OF MIMA-HERELLEA INFECTIONS.

Authors:  D TAPLIN; N ZAIAS
Journal:  JAMA       Date:  1963-12-07       Impact factor: 56.272

2.  DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates.

Authors:  G Prevost; B Jaulhac; Y Piemont
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia.

Authors:  N M Anstey; B J Currie; K M Withnall
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients.

Authors:  J F Timsit; V Garrait; B Misset; F W Goldstein; B Renaud; J Carlet
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

5.  Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting.

Authors:  M J Struelens; R Bax; A Deplano; W G Quint; A Van Belkum
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

6.  Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains.

Authors:  P J Bouvet; S Jeanjean; J F Vieu; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Prevalence of gram-negative rods in the normal pharyngeal flora.

Authors:  S Rosenthal; I B Tager
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

8.  Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting.

Authors:  Y Gräser; I Klare; E Halle; R Gantenberg; P Buchholz; H D Jacobi; W Presber; G Schönian
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii.

Authors:  H Seifert; A Schulze; R Baginski; G Pulverer
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  A study of the relationships between antibiotic resistance phenotypes, phage-typing and biotyping of 117 clinical isolates of Acinetobacter spp.

Authors:  M L Joly-Guillou; E Bergogne-Berezin; J F Vieu
Journal:  J Hosp Infect       Date:  1990-07       Impact factor: 3.926

View more
  20 in total

Review 1.  Acinetobacter species as nosocomial pathogens.

Authors:  D H Forster; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

2.  Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Authors:  R Pantophlet; L Brade; L Dijkshoorn; H Brade
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.

Authors:  Aspasia Katragkou; Maria Kotsiou; Charalampos Antachopoulos; Alexis Benos; Danai Sofianou; Maria Tamiolaki; Emmanuel Roilides
Journal:  Intensive Care Med       Date:  2006-06-21       Impact factor: 17.440

4.  Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

5.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.

Authors:  José Garnacho-Montero; C Ortiz-Leyba; Esteban Fernández-Hinojosa; Teresa Aldabó-Pallás; Aurelio Cayuela; Juan A Marquez-Vácaro; Andrés Garcia-Curiel; F J Jiménez-Jiménez
Journal:  Intensive Care Med       Date:  2005-03-23       Impact factor: 17.440

6.  Acinetobacter baumannii colonization in ventilated preterm infants.

Authors:  B Nagels; E Ritter; P Thomas; H Schulte-Wissermann; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

7.  Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

Authors:  X Corbella; A Montero; M Pujol; M A Domínguez; J Ayats; M J Argerich; F Garrigosa; J Ariza; F Gudiol
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 8.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

9.  Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach.

Authors:  Jesús Rodríguez-Baño; Lola García; Encarnación Ramírez; Luis Martínez-Martínez; Miguel A Muniain; Felipe Fernández-Cuenca; Margarita Beltrán; Juan Gálvez; Jose M Rodríguez; Carmen Velasco; Concepción Morillo; Federico Perez; Andrea Endimiani; Robert A Bonomo; Alvaro Pascual
Journal:  Am J Infect Control       Date:  2009-05-19       Impact factor: 2.918

10.  Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.

Authors:  Teena Chopra; Dror Marchaim; Paul C Johnson; Reda A Awali; Hardik Doshi; Indu Chalana; Naomi Davis; Jing J Zhao; Jason M Pogue; Sapna Parmar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.